ETPrime

Godavari Drugs Share Price

  • 93.493.49 (3.87%)
  • Volume: 1,966
BSE
  • Closed
  • Last Updated On: 09 May, 2025, 03:36 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Godavari Drugs Share Price
  • 93.493.49 (3.87%)
  • Volume: 1,966
Advertisment

Godavari Drugs share price insights

  • Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Company has spent 3.14% of its operating revenues towards interest expenses and 3.27% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Godavari Drugs Ltd. share price moved up by 3.87% from its previous close of Rs 90.00. Godavari Drugs Ltd. stock last traded price is 93.49

    Share PriceValue
    Today/Current/Last-93.49
    Previous Day-90.00

InsightsGodavari Drugs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		11.45
    EPS - TTM
    (₹)    		8.17
    MCap
    (₹ Cr.)    		70.40
    Sectoral MCap Rank
    		137
    PB Ratio
    (x)    		1.74
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.47
    3 Months0.18
    6 Months0.33
    1 Year0.33
    3 Years0.88
    		-0.47
    VWAP
    (₹)    		90.68
    52W H/L
    (₹)
    155.00 / 79.00

    Godavari Drugs Share Price Returns

    1 Day3.87%
    1 Week5.03%
    1 Month1.87%
    3 Months-13.11%
    1 Year-3.42%
    3 Years29.58%
    5 Years507.08%

    ET Stock ScreenersTop Score Companies

    Check whether Godavari Drugs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Godavari Drugs News & Analysis

    View all Godavari Drugs Share News & Announcements

    Godavari Drugs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Godavari Drugs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Godavari Drugs Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 3.14% of its operating revenues towards interest expenses and 3.27% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
      Total Income29.6526.1032.9738.7543.16
      Total Income Growth (%)13.61-20.85-14.91-10.229.14
      Total Expenses27.6223.7729.5334.7340.14
      Total Expenses Growth (%)16.21-19.51-14.99-13.498.58
      EBIT2.032.333.454.023.02
      EBIT Growth (%)-12.90-32.36-14.2833.3417.24
      Profit after Tax (PAT)0.771.091.632.661.22
      PAT Growth (%)-29.51-33.25-38.74118.0342.66
      EBIT Margin (%)6.858.9410.4610.386.99
      Net Profit Margin (%)2.594.174.956.872.83
      Basic EPS (₹)1.021.452.173.531.62
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue157.33160.28161.38123.0896.03
      Total Revenue Growth (%)-1.84-0.6831.1228.1714.60
      Total Expenses150.32155.57154.36117.3793.74
      Total Expenses Growth (%)-3.380.7931.5125.2214.25
      Profit after Tax (PAT)5.553.795.254.132.00
      PAT Growth (%)46.57-27.8227.06106.3265.57
      Operating Profit Margin (%)7.615.406.127.345.43
      Net Profit Margin (%)3.542.373.253.362.09
      Basic EPS (₹)7.375.036.975.482.66

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Insights

      • Contingent Liabilities Coverage

        Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets134.75121.43101.4191.1483.92
      Total Assets Growth (%)10.9719.7411.278.6012.42
      Total Liabilities95.7988.0271.7866.7563.66
      Total Liabilities Growth (%)8.8322.627.544.8512.89
      Total Equity38.9733.4229.6324.3920.26
      Total Equity Growth (%)16.6112.7921.4820.3810.95
      Current Ratio (x)1.081.181.291.341.19
      Total Debt to Equity (x)1.431.000.691.151.29
      Contingent Liabilities0.500.500.390.300.37

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 13.22 cr for investing activities which is an YoY increase of 53.05%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities18.4113.2211.231.336.24
      Net Cash used in Investing Activities-13.22-8.64-4.97-1.25-6.68
      Net Cash flow from Financing Activities-5.65-3.77-5.620.130.34
      Net Cash Flow-0.460.810.640.21-0.10
      Closing Cash & Cash Equivalent2.623.082.281.641.43
      Closing Cash & Cash Equivalent Growth (%)-14.9735.5138.9514.84-6.51
      Total Debt/ CFO (x)3.022.531.8121.154.18

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)14.2411.3217.7016.929.87
      Return on Capital Employed (%)22.6018.0822.6122.1815.91
      Return on Assets (%)4.113.115.174.522.38
      Interest Coverage Ratio (x)2.832.694.062.731.79
      Asset Turnover Ratio (x)1.221.431.67134.59114.03
      Price to Earnings (x)12.6315.089.408.354.35
      Price to Book (x)1.801.711.661.410.43
      EV/EBITDA (x)8.838.275.825.955.24
      EBITDA Margin (%)8.886.627.178.346.64

      No reported Financial Ratios are available.

    Financial InsightsGodavari Drugs

    • Income (P&L)
    • Balance Sheet
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 3.14% of its operating revenues towards interest expenses and 3.27% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Contingent Liabilities Coverage

        Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 13.22 cr for investing activities which is an YoY increase of 53.05%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Godavari Drugs Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Godavari Drugs Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Godavari Drugs11.451.8114.2422.604.118.447.613.547.371.081.433.02
          Fervent Syn-8.353.01-42.27-42.00-42.08120.44-52.67-52.82-4.28795.380.000.00
          Makers Labs12.300.74-9.93-1.58-3.8814.86-1.88-4.60-10.621.880.2821.05
          Sunil Healthcare-42.961.01-2.623.16-1.12-0.163.57-1.98-1.741.100.95-4.21
          Biofil Chem112.093.743.894.881.503.472.261.770.441.350.020.18
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Ind Swift Ltd
          • Medi-Caps Ltd
          • Sandu Pharma
          • Transchem Ltd
          • Roopa Ind

          Choose from Stocks

            See All Parameters

          Peers InsightsGodavari Drugs

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Godavari Drugs Shareholding Pattern

            • Loading...
              Showing Godavari Drugs Shareholding as on Mar 2025
              CategoryMar 2025Dec 2024Sep 2024Jun 2024
              Promoters52.6352.6352.6353.16
              Pledge0.250.250.251.25
              FII0.000.000.000.00
              DII0.000.000.000.00
              Mutual Funds0.000.000.000.00
              Others47.3747.3747.3746.84
            • Showing Shareholding as on Mar 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters39,63,20052.63 %0.00
              Pledge10,0000.25 %0.00
              Others35,67,30047.37 %0.00

            Godavari Drugs MF Ownership

            MF Ownership details are not available.

            Top Searches:
            Godavari Drugs News Godavari Drugs Quarterly Results Godavari Drugs Dividend Godavari Drugs Q1 ResultsGodavari Drugs Q2 ResultsGodavari Drugs Q3 ResultsGodavari Drugs Q4 Results

            Godavari Drugs Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Feb 12, 2025Feb 06, 2025Board MeetingQuarterly Results
              Nov 14, 2024Nov 08, 2024Board MeetingQuarterly Results
              Aug 29, 2024Aug 05, 2024AGMBook closure from Aug 24, 2024 to Aug 29, 2024
              Aug 14, 2024Aug 09, 2024Board MeetingQuarterly Results
              May 30, 2024May 24, 2024Board MeetingQuarterly Results
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final 22%0.0-Aug 17, 1998

            • No other corporate actions details are available.

            About Godavari Drugs

            Godavari Drugs Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 70.40 Crore) operating in Pharmaceuticals sector. Godavari Drugs Ltd. key Products/Revenue Segments include Bulk Drugs, Income From Construction Work and Raw Materials for the year ending 31-Mar-2017. Show More

            • Executives

            • Auditors

            • GJ

              Ghanshyam Jaju

              Chairman
              MK

              Mukund Kakani

              Managing Director
              MJ

              Mohit Jaju

              WholeTime Director & CFO
              DU

              Dinesh Udpa

              Ind. Non-Executive Director
              Show More
            • Ayyadevara & Co.
              V Sridhar & Co.

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            1-8-303/34,Mayfair,Secunderabad, Telangana - 500003

            Contact

            info@godavaridrugs.com

            http://www.godavaridrugs.com

            More Details

            FAQs about Godavari Drugs share

            • 1. What's Godavari Drugs share price today and what are Godavari Drugs share returns ?
              Godavari Drugs share price is Rs 93.49 as on 09 May, 2025, 03:36 PM IST. Godavari Drugs share price trend:
              • Last 1 Month: Godavari Drugs share price moved up by 1.87%
              • Last 12 Months: Godavari Drugs share price moved down 3.42%
              • Last 3 Years: Godavari Drugs Share price moved up by 29.58%
            • 2. Who are the peers for Godavari Drugs in Pharmaceuticals sector?
              Within Pharmaceuticals sector Godavari Drugs, Fervent Synergies Ltd., Sunil Healthcare Ltd., Ind-Swift Ltd., Biofil Chemicals & Pharmaceuticals Ltd., MediCaps Ltd., Transchem Ltd., Makers Laboratories Ltd., Gujarat Terce Laboratories Ltd., Roopa Industries Ltd. and Sandu Pharmaceuticals Ltd. are usually compared together by investors for analysis.
            • 3. What are the key metrics to analyse Godavari Drugs Share Price?
              Key Metrics for Godavari Drugs are:
              • PE Ratio of Godavari Drugs is 11.45
              • Price/Sales ratio of Godavari Drugs is 0.45
              • Price to Book ratio of Godavari Drugs is 1.74
            • 4. What is the market cap of Godavari Drugs?
              Within the Pharmaceuticals sector, Godavari Drugs stock has a market cap rank of 137. Godavari Drugs has a market cap of Rs 70.40 Cr.
            • 5. Who owns Godavari Drugs?
                • Promoter holding have gone down from 53.16 (30 Jun 2024) to 52.63 (31 Mar 2025)
                • Other investor holding has gone up from 46.84 (30 Jun 2024) to 47.37 (31 Mar 2025)
            • 6. What is the CAGR of Godavari Drugs?
              The CAGR of Godavari Drugs is 6.31.
            • 7. What has been highest price of Godavari Drugs share in last 52 weeks?
              In last 52 weeks Godavari Drugs share had a high price of Rs 155.00 and low price of Rs 79.00
            • 8. What are the returns for Godavari Drugs share?
              Return Performance of Godavari Drugs Shares:
              • 1 Week: Godavari Drugs share price moved up by 5.03%
              • 1 Month: Godavari Drugs share price moved up by 1.87%
              • 6 Month: Godavari Drugs share price moved down by 22.86%
            • 9. What are the Godavari Drugs quarterly results?
              Total Revenue and Earning for Godavari Drugs for the year ending 2024-03-31 was Rs 157.33 Cr and Rs 5.55 Cr on Standalone basis. Last Quarter 2024-12-31, Godavari Drugs reported an income of Rs 29.65 Cr and profit of Rs 0.77 Cr.
            • 10. What is the PE & PB ratio of Godavari Drugs?
              The PE ratio of Godavari Drugs stands at 11.02, while the PB ratio is 1.74.
            • 11. Who is the chairman of Godavari Drugs?
              Ghanshyam Jaju is the Chairman of Godavari Drugs

            Trending in Markets

            Top Gainers As on 03:59 PM | 09 May 2025

            KPR Mill1,306.25
            117.41 (9.88%)
            YES Bank20.02
            1.79 (9.82%)
            Welspun India146.90
            9.02 (6.54%)
            Craftsman Automation4,867.50
            290.40 (6.35%)
            Union Bank India122.90
            7.33 (6.34%)

            Top Losers As on 03:59 PM | 09 May 2025

            Sonata Software365.70
            -26.91 (-6.86%)
            Chola Fin Holdings1,718.00
            -111.00 (-6.07%)
            MCX India5,670.50
            -334.00 (-5.57%)
            Poly Medicure2,526.80
            -148.00 (-5.54%)
            Raymond1,456.20
            -84.21 (-5.47%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Godavari Drugs Share Price
            The Economic Times
            BrowseCompanies: